We showed previously that nimodipine prevents in vivo intra-hyppocampal accumulation of IL-1β triggered by Aβ inoculation9, thus nimodipine administration might be a viable therapeutic strategy for AD. This evidence concerns the gene IL1B and Alzheimer disease.